APOE (Apolipoprotein E) is a key gene in lipid metabolism, best known for its link to Alzheimer's disease. During menopause, estrogen decline alters lipid profiles, increasing cardiovascular risk. APOE variants (ε2, ε3, ε4) modulate blood lipid levels and could theoretically influence individual risk shifts in menopause. However, evidence for a direct role of APOE in menopause is weak and inconsistent. Some studies suggest an association between APOE ε4 and earlier menopause or greater cognitive decline, while others find no significant link. Clinical relevance remains unclear. APOE testing for menopause is not standard and should not be pursued without medical guidance. Lifestyle factors (diet, exercise, stress) have a far greater impact on menopausal well-being than single gene variants. Evidence: unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-8fba1b0861c2d85084793ae3